Abstract
In recent years, improvements in endovascular equipment and the technical skills of operators have led to an increasing number of percutaneous common femoral artery (CFA) interventions. However, there are few reports of the detailed treatment strategy for CFA intervention and its subsequent clinical outcomes. We evaluated the safety and efficacy of endovascular therapy (EVT) with a high-pressure balloon for CFA disease. Fifty-five consecutive patients (59 lesions) who underwent EVT with high-pressure ballooning were analyzed retrospectively. The primary endpoint was clinically driven target lesion revascularization (TLR). The median follow-up was 34.0 months. The mean age was 68.0 ± 10.1 years, and 70.1% were men. The procedural success rate was 98.3%. All patients underwent high-pressure balloon angioplasty (mean pressure 17.7 atm). Clinically driven TLR-free rates at 2, 3, and 4 years were 88.7%, 77.9%, and 74.2%, respectively. Endovascular interventions with high-pressure ballooning for CFA showed an acceptable mid-term freedom rate from TLR.
Similar content being viewed by others
References
Sacks D. The TransAtlantic inter-society consensus (TASC) on the management of peripheral arterial disease. J Vasc Interv Radiol. 2003;14:S351.
Mukherjee D, Inahara T. Endarterectomy as the procedure of choice for atherosclerotic occlusive lesions of the common femoral artery. Am J Surg. 1989;157:498–500.
Cardon A, Aillet S, Jarno P, Bensalah K, Le Du J, Idrissi A, et al. Endarterectomy of the femoral tripod: long-term results and analysis of failure factors. Ann Chir. 2001;126:777–82.
Ballotta E, Gruppo M, Mazzalai F. Da Giau G. Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study. Surgery. 2010;147:268e74.
Kechagias A, Ylönen K, Biancari F. Long-term outcome after isolated endarterectomy of the femoral bifurcation. World J Surg. 2008;32:51–4.
Bonvini RF, Rastan A, Sixt S, Noory E, Schwarz T, Frank U, et al. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol. 2011;58:792–8.
Baumann F, Ruch M, Willenberg T, Dick F, Do DD, Keo HH, et al. Endovascular treatment of common femoral artery obstructions. J Vasc Surg. 2011;53:1000–6.
Soga Y, Tomoi Y, Sato K, Iida O, Yokoi H. Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease. Cardiovasc Interv Ther. 2013;28:250–7.
Davies RS, Adair W, Bolia A, Fishwick G, Sayers RD, McCarthy MJ. Endovascular treatment of the common femoral artery for limb ischemia. Vasc Endovasc Surg. 2013;47:639–44.
Sandgren T, Sonesson B, Ahlgren R, Länne T. The diameter of the common femoral artery in healthy human: influence of sex, age, and body size. J Vasc Surg. 1999;29:503–10.
Stricker H, Jacomella V. Stent-assisted angioplasty at the level of the common femoral artery bifurcation: midterm outcomes. J Endovasc Ther. 2004;11:281e6.
Thiney PO, Millon A, Boudjelit T, Della Schiava N, Feugier P, Lermusiaux P. Angioplasty of the common femoral artery and its bifurcation. Ann Vasc Surg. 2015;29:960–7.
Kang JL, Patel VI, Conrad MF, Lamuraglia GM, Chung TK, Cambria RP. Common femoral artery occlusive disease: contemporary results following surgical endarterectomy. J Vasc Surg. 2008;48:872–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
This study was not financially supported by any company, grant, or fund. The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
The study protocol was based on the regulations of the hospital’s ethics committee. Patient enrollment was performed according to the principles of the Declaration of Helsinki.
Informed consent
All participating patients provided written informed consent.
Rights and permissions
About this article
Cite this article
Nakao, M., Yamaguchi, J., Otsuki, H. et al. Clinical outcomes of high-pressure balloon angioplasty for common femoral artery disease in contemporary practice. Cardiovasc Interv and Ther 34, 340–344 (2019). https://doi.org/10.1007/s12928-018-0557-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12928-018-0557-2